Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.

about

Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.

Item

http://www.wikidata.org/entity/Q47562442

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Comparing transfusion reaction ...... of ISTARE haemovigilance data.

@en

Comparing transfusion reaction ...... of ISTARE haemovigilance data.

@nl

type

Item

label

Comparing transfusion reaction ...... of ISTARE haemovigilance data.

@en

Comparing transfusion reaction ...... of ISTARE haemovigilance data.

@nl

prefLabel

Comparing transfusion reaction ...... of ISTARE haemovigilance data.

@en

Comparing transfusion reaction ...... of ISTARE haemovigilance data.

@nl

P1476

Comparing transfusion reaction ...... of ISTARE haemovigilance data.

@en

P2093

Clive Richardson

http://www.w3.org/2001/XMLSchema#string

Constantina Politis

http://www.w3.org/2001/XMLSchema#string

Johanna C Wiersum-Osselton

http://www.w3.org/2001/XMLSchema#string

Martin R Schipperus

http://www.w3.org/2001/XMLSchema#string

Philippe Renaudier

http://www.w3.org/2001/XMLSchema#string

Pierre Robillard

http://www.w3.org/2001/XMLSchema#string

Rutger A Middelburg

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Solvent/detergent-treated plasma: composition, efficacy, and safety.

Haemovigilance: are there significant differences among plasma products?

Adverse effects of plasma transfusion

Pathogen reduction of blood components.

The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.

Current status of solvent/detergent-treated frozen plasma.

Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG.

Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers.

P304

727-734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.15082

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P50

Johanna G van der Bom

Nicholas H Saadah

P577

2018-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29318576

http://www.w3.org/2001/XMLSchema#string